Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targretin in AIDS-Related Kaposi's Sarcoma
NCT00002212Phase 2Completed
- Sponsor
- Ligand Pharmaceuticals
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bexarotene in Kaposi sarcoma (KS), sponsored by Ligand Pharmaceuticals. Primary endpoints: Safety and Tolerability and Objective Response Rate. Status: completed.
02
Drugs
bexarotene
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT00002212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002212.